Findings suggest that Bacillus clausii and Bacillus coagulans may serve as effective complementary therapies to mitigate tissue damage and thrombotic events in COVID-19 infections, with no adverse effects observed https://pmc.ncbi.nlm.nih.gov/articles/PMC11763649/ Probiotics have shown efficacy in preventing and reducing infections caused by common viruses, including rotavirus, norovirus, hepatitis, human papillomavirus (HPV), human immunodeficiency virus (HIV), and herpes simplex virus (HSV)